EDGAR Filing Documents for 0001571049-18-000565

Form 8-K - Current report:

SEC Accession No. 0001571049-18-000565

Filing Date

2018-12-06

Accepted

2018-12-06 16:15:30

Documents

Period of Report

2018-11-30

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tv508496_8k.htm	8-K	25717
2	EXHIBIT 3.1	tv508496_ex3-1.htm	EX-3.1	7003
3	EXHIBIT 99.1	tv508496_ex99-1.htm	EX-99.1	20383
4	GRAPHIC	tv508496_ex99-1img1.jpg	GRAPHIC	6850
	Complete submission text file	0001571049-18-000565.txt		64113

Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512

Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990

Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)